Lamban, Rey D.

HRN: 28-81-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFUROXIME 750MG (VIAL)
04/30/2026
05/07/2026
IV
750mg
Q8
S/P OR TBW Patella R
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines